Tesamorelin + Ipamorelin 30mg Pen Bali | Atlas

Price range: Rp4,100,000.00 through Rp4,700,000.00 ~$248.48–$284.85

Explore the Atlas Longevity Tesamorelin + Ipamorelin 30mg Peptide Pen, a dual-peptide research formulation combining two compounds associated with growth hormone signalling.

This pre-mixed research pen contains:

  • Tesamorelin: 20mg
  • Ipamorelin: 10mg
  • Total Peptide Content: 30mg
  • Ingredient Ratio: 2:1
  • Cartridge Volume: 3mL
  • Total Pen Units: 300
  • Dial Range: 1–60 units
  • Format: Pre-mixed peptide pen

Tesamorelin is a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin is an experimental growth hormone secretagogue.

For laboratory research only. This combined formulation is not approved for human administration.

10 Needles + 10 Alcohol pads included.
Description

Tesamorelin + Ipamorelin 30mg Peptide Pen Bali

Dual Growth Hormone Signalling Research Blend

The Atlas Longevity Tesamorelin 20mg + Ipamorelin 10mg Blend combines two peptides associated with distinct pathways involved in growth hormone regulation.

Tesamorelin acts through the GHRH receptor, while Ipamorelin acts through the growth hormone secretagogue receptor (GHS-R1a).

The two pathways are relevant to endocrine research, although the safety and effectiveness of this specific combination have not been established through adequate human clinical trials.

What’s Inside the 30mg Blend?

Ingredient Labelled Quantity Research Focus
Tesamorelin 20mg GHRH receptor signalling
Ipamorelin 10mg Growth hormone secretagogue receptor signalling
Total 30mg Experimental endocrine research

The formulation contains a 2:1 ratio of Tesamorelin to Ipamorelin by mass.

What Is Tesamorelin?

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone.

It stimulates GHRH receptors in the pituitary gland, which can increase endogenous growth hormone secretion and downstream IGF-1 activity.

Research involving Tesamorelin has examined:

  • Growth hormone secretion
  • Pituitary endocrine signalling
  • IGF-1 regulation
  • Visceral adipose tissue
  • Metabolic pathways
  • Body composition in specific clinical populations

An authorised Tesamorelin medicine is used in certain jurisdictions to reduce excess abdominal fat in adults with HIV-associated lipodystrophy.

That approval does not extend to this Tesamorelin + Ipamorelin blend or establish that the blend is suitable for general weight loss.

What Is Ipamorelin?

Ipamorelin is an experimental peptide classified as a growth hormone secretagogue.

It acts primarily through the GHS-R1a receptor, which is also associated with ghrelin signalling.

Research has investigated Ipamorelin in relation to:

  • Growth hormone secretagogue activity
  • Pituitary signalling
  • Ghrelin receptor activation
  • Endocrine regulation
  • Growth hormone release mechanisms

Ipamorelin is not an established approved treatment for muscle growth, fat loss, recovery or anti-ageing.

Why Are Tesamorelin and Ipamorelin Studied Together?

Tesamorelin and Ipamorelin interact with different receptors associated with growth hormone regulation.

Tesamorelin: GHRH receptor pathway.

Ipamorelin: GHS-R1a receptor pathway.

These distinct mechanisms make the combination relevant to experimental endocrine research.

However, combining the two peptides does not establish enhanced effectiveness, improved safety or additional clinical benefits.

Tesamorelin vs Ipamorelin

Feature Tesamorelin Ipamorelin
Peptide Class GHRH analogue Growth hormone secretagogue
Primary Receptor GHRH receptor GHS-R1a
Research Focus Pituitary GH signalling Ghrelin receptor-mediated GH signalling
Content in Pen 20mg 10mg

Growth Hormone and Metabolic Research

The individual compounds have been investigated in research involving:

  • Growth hormone signalling
  • Pituitary hormone responses
  • IGF-1 pathways
  • Endocrine regulation
  • Metabolic physiology
  • Body composition mechanisms

Clinical results from authorised Tesamorelin medicines cannot automatically be applied to the combined pen formulation.

Atlas Longevity Pen Specifications

Specification Details
Brand Atlas Longevity
Product Tesamorelin + Ipamorelin Blend
Total Labelled Content 30mg
Tesamorelin 20mg
Ipamorelin 10mg
Ingredient Ratio 2:1
Cartridge Volume 3mL
Total Cartridge Units 300
Volume Per Unit 0.01mL
Dial Range 1–60 units
Maximum Dial Setting 60 units
Format Pre-mixed research peptide pen

The Atlas Pen dial resets to zero after operation. Remaining cartridge contents stay inside the cartridge.

Pre-Mixed Research Formulation

This product is presented as a pre-mixed research peptide pen.

The stability and compatibility of Tesamorelin and Ipamorelin together in a single cartridge require appropriate formulation-specific testing.

A pre-filled pen presentation does not establish sterility or suitability for human injection.

Quality and Batch Documentation

Contact Atlas Longevity to request available batch-specific analytical documentation.

For combination products, appropriate testing should verify the identity and quantity of both peptides.

A peptide purity Certificate of Analysis does not establish sterility, formulation stability or pharmaceutical approval.

Storage and Handling

Follow verified storage and expiry instructions for the specific formulation and batch.

Protect from excessive heat, direct sunlight and contamination.

Do not assume that storage instructions from authorised Tesamorelin medicines apply to this combined formulation.

Safety Information

Tesamorelin can increase IGF-1 activity and affect glucose regulation.

Authorised Tesamorelin medicines carry important warnings and contraindications, including considerations involving active malignancy, pregnancy and glucose intolerance.

Ipamorelin has not been adequately evaluated for long-term human safety.

The combined formulation has no established approved human dosing protocol.

Atlas Longevity Bali

Atlas Longevity provides information about experimental peptide formulations and endocrine research products in Bali, Indonesia.

Contact our team for product specifications, available batch documentation and regulatory enquiries.

Any supply must comply with applicable Indonesian regulations.


Frequently Asked Questions

What is Tesamorelin + Ipamorelin 30mg Blend?

It is an experimental dual-peptide formulation containing Tesamorelin and Ipamorelin, two compounds associated with growth hormone signalling.

How much Tesamorelin and Ipamorelin is in the pen?

The pen is labelled as containing 20mg Tesamorelin and 10mg Ipamorelin, giving a total of 30mg.

What is Tesamorelin?

Tesamorelin is a synthetic GHRH analogue that acts through the pituitary GHRH receptor.

What is Ipamorelin?

Ipamorelin is an experimental growth hormone secretagogue that acts through the GHS-R1a receptor.

Why are Tesamorelin and Ipamorelin combined?

They act through different receptor pathways associated with growth hormone regulation. Their combination has not been established as more effective or safer than either compound individually.

Is Tesamorelin approved for medical use?

Certain Tesamorelin medicines are approved in specific jurisdictions for excess abdominal fat associated with HIV lipodystrophy. That approval does not apply to this combined formulation.

Is this blend proven to reduce abdominal fat?

No. Clinical findings involving authorised Tesamorelin medicines cannot be assumed to apply to the Tesamorelin + Ipamorelin combination.

Is this blend proven to improve muscle growth or recovery?

No. There is insufficient high-quality human evidence to establish these benefits for the combined formulation.

How many units are in the Atlas Pen?

The Atlas Pen contains 300 volumetric units in a 3mL cartridge. Each unit represents 0.01mL.

Does the pen require mixing?

The product is presented as a pre-mixed research formulation, with no separate reconstitution step.

Is the Tesamorelin + Ipamorelin Pen approved for medical use?

No. This specific combined pen formulation is not an established approved medical treatment.

Is this pen suitable for injection?

A pre-filled pen format or peptide purity result does not establish sterility, safety or suitability for human injection.

How should the pen be stored?

Follow the verified storage and expiry instructions for the specific batch and formulation.

Is a Certificate of Analysis available?

Contact Atlas Longevity to request available batch-specific analytical documentation.

Is Tesamorelin the same as Ipamorelin?

No. Tesamorelin is a GHRH analogue, while Ipamorelin is a growth hormone secretagogue acting through GHS-R1a.


Research Disclaimer

For laboratory research only. Not for human consumption or self-administration.

The safety, effectiveness and stability of this combined peptide formulation have not been established for human administration.

This product is not intended to diagnose, treat, cure or prevent any disease.